Make your science impossible to ignore.

We're a specialist growth partner for funded biotech and life sciences founders. We build investor visibility, thought leadership, and AI-search presence through seven productized systems: social media management, founder LinkedIn ghostwriting, content engine, SEO blog writing, GEO/AEO optimization, website development, and investor and BD outreach. Every engagement runs on a defined scope with defined deliverables, no open-ended retainers, no scope creep.

We work exclusively with funded biotech and life sciences companies, typically pre-seed through Series B. Our clients are founders who have strong science but limited visibility: losing investor rounds to companies with weaker data, struggling to get pharma BD conversations started, or watching top talent choose noisier competitors. If that describes your situation, we're probably the right fit.

Your audience, biotech VCs, pharma BD leads, KOLs, and senior scientists, are exceptionally allergic to generic promotional content. They respond to scientific credibility, clear thinking, and demonstrated expertise. Our biotech content marketing systems are built around this reality: everything we produce is grounded in your actual science, written to be credible to a technical reader, and calibrated to the specific platforms where your target investors and partners actually spend time. Generic "10 social media tips" content would actively hurt you with this audience.

Most clients see meaningful inbound change, investor inquiries, partnership conversations, or speaking invitations, within 60 to 90 days. The system takes a few weeks to build momentum because it's grounded in real positioning and real content, not shortcuts. Six to twelve months in, the compounding effect becomes substantial: a content library that keeps generating inbounds, a founder LinkedIn profile that investors recognise on sight, and AI-search presence that outlasts the engagement itself.

GEO (Generative Engine Optimization) and AEO (Answer Engine Optimization) are the practices of making your company visible inside AI-generated answers, in ChatGPT, Perplexity, Google AI Overviews, and Claude. A growing percentage of investor research and BD scoping now begins with an AI query, not a Google search. If ChatGPT can't name you when asked "who's working on [your therapeutic area]?", you're invisible to a fast-growing slice of your audience. We engineer your presence in these systems through structured data, llm.txt, brand entity building, and AI-readable content reformatting.

Our free 30-page audit covers your current investor visibility, LinkedIn authority, AI-search presence, and competitive positioning, benchmarked against three to five named competitors. It's delivered within 48 hours and comes with no sales call requirement and no commitment. We invest 8–12 hours per audit. We do it for free because the work speaks for itself: most founders who receive the audit understand exactly why they need Bioverse before we've said a word.

Three things set us apart. First, we work exclusively with biotech and life sciences, we understand the science, the regulatory context, the investor landscape, and the BD dynamics. Most agencies don't. Second, everything is productized: defined scope, defined outputs, defined timelines. You always know what you're getting and when. Third, we optimize for outcomes that matter in biotech specifically, investor inbounds, pharma BD conversations, and qualified talent applications, not impressions and follower counts that look good in a deck but move nothing in the real world.